Yahoo Web Search

Search results

1. • 

     Lilly's (LLY) Migraine Drug Fails Vis-a-Vis Pfizer's Nurtec ODT

     Zacks via Yahoo Finance· 10 months ago

     Results from a post-approval study show that treatment with Lilly's (LLY) Emgality failed to achieve...

2. • 

     Eli Lilly's Migraine Candidate Flunks Head-To-Head Study With Pfizer's Newly Acquired Drug

     Benzinga via Yahoo Finance· 10 months ago

     Eli Lilly And Co (NYSE: LLY) announced the results of the CHALLENGE-MIG clinical trial of Emgality...

3. • 

     Menstrual Migraine: Role of Estrogen and Self-Care Tips

     Verywell Health via Yahoo News· 8 months ago

     Menstrual migraines develop around a person's menstrual period, typically manifesting a couple of...

4. • 

     One Woman Shares How She Found Some Migraine Relief – After Experiencing the Debilitating Disease...

     SheKnows via Yahoo News· 4 months ago

     Amanda, a 35-year-old mother, outdoor enthusiast and electrical engineer, will always remember May...

5. • 

     Key Features of Cluster Headache vs. Migraine Symptoms

     Verywell Health via Yahoo News· 5 months ago

     Cluster headaches and migraines are complex headache disorders associated with significant and...

6. • 

     Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M

     Benzinga via Yahoo Finance· 1 year ago

     A federal jury has asked Eli Lilly And Company (NYSE: LLY) to pay Teva Pharmaceuticals International...

7. • 

     These Drugs Are the New First Line of Defense Against Migraine

     Verywell Health via Yahoo News· 3 weeks ago

     Illustration by Julie Bang for Verywell Health Fact checked by Nick Blackmer Key Takeaways CGRP...

8. • 

     9 Proven Ways to Treat and Prevent Migraines

     Men's Health via Yahoo News· 2 years ago

     If you've ever had a migraine, you know the feeling of wanting to put a drill to your head to somehow rid yourself of the pain, pressure, and throbbing....

9. • 

     Eli Lilly's migraine drug fails to prove superiority to Pfizer's

     Reuters via Yahoo News· 10 months ago

     The three-month study, which involved 580 patients, was the first-of-its-kind to compare the two...

10. • 

      AbbVie (ABBV) Gets EU Approval for Migraine Prevention Drug

      Zacks via Yahoo Finance· 8 months ago

      Following the approval, AbbVie's (ABBV) Aquipta is the first and the only oral CGRP receptor...